Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug symbols : Lly save search
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
fda drug approval treatment
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Published: 2024-03-08 (Crawled : 12:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
drug food meeting study
Global Therapeutic Antibody Market Research Report 2024: Monoclonal, Bispecific, Drug Conjugates, Others Insights and Forecasts 2019-2029
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.36%
H: 0.1%
C: -0.6%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
drug report antibody research global market
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published: 2024-02-07 (Crawled : 09:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.65%
H: 0.57%
C: -3.21%
first management drug application china
Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
Published: 2024-01-23 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: -4.99%
H: 0.0%
C: -0.06%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: -1.36%
H: 0.0%
C: -0.82%
WST | $385.73 -1.15% 0.0% 760K
|
Health Technology
|
| O: 0.67%
H: 0.46%
C: -1.49%
TFX | $211.17 0.03% 1.34% 200K
|
Health Technology
|
| O: 0.18%
H: 0.52%
C: -2.57%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.16%
H: 0.84%
C: 0.08%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -0.18%
H: 0.5%
C: -0.98%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
|
| O: 0.07%
H: 1.08%
C: -1.59%
drug global growth market
Global Erectile Dysfunction Drugs Market Research Report 2024: Novel Drug Launches Propel Growth, Growing Geriatric Population Drives Demand - Forecast to 2034
Published: 2024-01-16 (Crawled : 00:00) - prnewswire.com
MGRX | $0.2824 -6.52% 24K
|
|
| O: 3.28%
H: 4.38%
C: -0.19%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
PTPI | $0.635 -6.63% -7.1% 180K
|
|
| O: 0.38%
H: 0.0%
C: -7.58%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
drug propel report research global growing market
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
Published: 2024-01-15 (Crawled : 22:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
drug treatment heart market
Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
Published: 2024-01-05 (Crawled : 14:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
drug pipeline expansion immunology therapeutics
Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication
Published: 2023-12-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.95%
H: 3.83%
C: 2.79%
tyvyt drug china
HUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Terms
Published: 2023-12-13 (Crawled : 05:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
HCM | $18.405 0.85% 0.84% 58K
|
Health Technology
|
| O: -2.54%
H: 3.89%
C: 3.41%
elunate drug china
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
VNDA | $4.57 -1.3% -1.31% 1.5M
|
Health Technology
|
| O: 2.08%
H: 1.53%
C: 0.76%
drug food treatment pharmaceuticals application
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Published: 2023-11-28 (Crawled : 20:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
drug prism collaboration
Aspirin Drug Market to Soar to US$4.2 Billion by 2034, Driven by Combination Aspirin's Dominance | Future Market Insights, Inc.
Published: 2023-11-21 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.74%
H: 0.71%
C: 0.71%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.66%
H: 1.87%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.44%
H: 0.63%
C: -0.05%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
drug market
Global Cyclin-Dependent Kinase Inhibitor Drug Research Report 2023: Comprehensive Analysis of 45 Companies and 50+ Pipeline Drugs
Published: 2023-11-21 (Crawled : 18:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.44%
H: 0.63%
C: -0.05%
drug companies report pipeline research global
Redwire Announces First Spaceflight Mission for New Cutting-Edge Pharmaceutical Drug Development Lab, Partnering with Eli Lilly and Company to Expand Space Research to Study Heart Disease and Diabetes
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
drug disease company space research heart diabetes study
U.S. Food and Drug Administration (FDA) Approves FoundationOne®CDx as a Companion Diagnostic for Lilly’s Retevmo® (selpercatinib) for Certain Patients with Solid Tumors
Published: 2023-10-09 (Crawled : 18:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.21%
H: 2.8%
C: 1.37%
foundationone drug diagnostic food tumors companion
U.S. Food and Drug Administration Issues Complete Response Letter for Lebrikizumab Based on Inspection Findings at Third-Party Manufacturer
Published: 2023-10-02 (Crawled : 12:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
drug food response
Addressing Unmet Needs: Uveitis Market Report Provides Opportunities for Drug Developers
Published: 2023-08-03 (Crawled : 18:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
drug report market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.